New York, November 23, 2021 – The global antibiotics market size is expected to reach USD 74.87 Billion in 2028 at a CAGR of 3.9% during the forecast period, according to latest report by Reports and Data. Increasing efforts to develop antibiotics with novel mechanism of actions, development of semi-synthetic antibiotics to combat growing resistance to antibiotics, growing global prevalence of infectious diseases, and rapid advancements in R&D activities are key factors expected to drive market revenue growth over the forecast period. In addition, increasing use of advanced technologies such as genome mining and editing to discover and develop new natural products with different bioactivities and rising number of antibiotics in clinical trials are some other key factors expected to support revenue growth of the market going ahead.
Increasing incidence of severe bacterial infections such as bacterial gastroenteritis, pneumonia, and Urinary Tract Infections (UTIs), among others, and rising number of clinical trials and drug approvals are some key factors expected to drive market growth
Download PDF Sample Copy @ https://www.reportsanddata.com/sample-enquiry-form/1377
Antibiotics are extensively used to treat infectious diseases and bacterial infections, and can be bactericidal or bacteriostatic. These drugs work by inhibiting growth of a microorganism or destroying it by preventing cell wall synthesis, halting production of protein or nucleic acid, or by reducing permeability of the cytoplasmic membrane. Even though most antibiotics today are synthetic, they were originally derived from natural substances. Broad spectrum antibiotic is the most commonly used type of antibiotic and is generally regarded as safe. Over the recent past, extensive research & development activities have been carried out to discover new antibiotics with diverse mode of actions, and these activities are expected to continue in the years to come to develop more advanced antibiotics. Antibiotics are grouped into classes based on chemical structure and each antibiotic is effective only against certain bacteria. These antibiotics are being used to control and prevent infections and diseases and is one of the major factors expected to contribute to revenue growth of the market going ahead.
Combinations of antibiotics are used for treatment of chronic infections, certain bacterial infections that develop resistance to single antibiotics, and infections caused by various types of bacteria. Increasing accessibility to over-the-counter antibiotics is another key factor expected to drive market growth. However, increasing number of side effects associated with use of antibiotics and growing incidence of widespread antimicrobial resistance are some key factors that could hamper market revenue growth to significant extent over the forecast period.
To know more about the report @ https://www.reportsanddata.com/report-detail/antibiotics-market
Some Key Highlights from the Report:
- Cell wall synthesis inhibitors segment is expected to account for largest revenue share over the forecast period, attributable to increasing R&D activities on inhibition of cell wall synthesis to develop novel antibiotics and therapeutics, growing use of β-lactams and glycopeptide antibiotics to treat infections, and cell wall synthesis inhibitors being the most widely used class of antibiotics.
- Fluoroquinolones segment is expected to register robust revenue CAGR over the forecast period owing to development of novel fluoroquinolones with excellent bioavailability, increasing number of clinical trials to compare new fluoroquinolones, and increasing use of these antibiotics against pathogenic gram positive bacteria.
- Oral segment is expected to account for a significantly large revenue share attributable to rising preference for oral antibiotic therapy, increasing cost-effectiveness, and numerous advantages of oral administration over intravenous administration such as reduction in drug costs, low burden on healthcare facilities, and no risk of cannula-related infections.
- Hospital pharmacies segment is expected to register considerably high revenue growth rate over the forecast period, owing to increasing availability of wide range of antibiotics, growing hospital admissions due to infectious diseases, and implementation of stringent policies to streamline antibiotic use.
- Asia Pacific is expected to register a steady revenue CAGR during the forecast period attributable to increasing healthcare expenditure, rising number of pharmaceutical and biotechnology companies, increasing use of antibiotics to combat rising prevalence of infectious diseases, and availability of generic drugs in countries in the region.
- Key companies profiled in the market report include Bristol-Myers Squibb Co., AstraZeneca plc, The Menarini Group, GlaxoSmithKline plc, Bayer HealthCare AG, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., and Sanofi.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1377
For the purpose of this report, Reports and Data has segmented the global antibiotics market based on type, product outlook, administration mode, end use, and region:
Type Outlook (Revenue, USD Billion; 2018-2028)
- Protein
- DNA
- RNA
- Cell Wall Synthesis Inhibitors
- Mycolic Acid Inhibitors
Product Outlook (Revenue, USD Billion; 2018-2028)
- Carbapenems
- Penicillin
- Fluoroquinolones
- Macrolides
- Others
Administration Route Outlook (Revenue, USD Billion; 2018-2028)
- Oral
- Topical
- Sublingual
- Inhalation
- Others
End Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Buy Now Premium Research Report – https://www.reportsanddata.com/checkout-form/1377
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Similar Research reports by Reports and Data of Pharma and Healthcare Industry:
Brain Bionics Market By Type (Deep Brain Simulators, Spinal Cord Simulators, Vagus Nerves Simulators), By Application (Hospitals, Clinics, Others), and By Region Forecast To 2028
Cancer Supportive Care Products Market By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovarian Cancer, Melanoma, Others), By Drug Class (Nonsteroidal Anti-inflammatory Drugs, Anti-infective, Antiemetic Drugs, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics), and By Region Forecast To 2028
Clostridium Diagnostics Market By Product Type (Molecular Diagnostics, Immunoassays), By Application (Hospitals, Clinics, Independent Laboratories, Others), By Region
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-antibiotics-market